Barry E. Greene
Overview
Barry E. Greene received an average of $30M in total compensation, including $394K in salary, at Sage Therapeutics between 2020 and 2021. Barry Greene also received an average of $3M at Alnylam Pharmaceuticals from 2007 to 2020.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
Sage TherapeuticsChief Executive Officer and President
Sage TherapeuticsChief Executive Officer and President
Alnylam PharmaceuticalsFormer President
Alnylam PharmaceuticalsFormer President
Alnylam PharmaceuticalsFormer President
Alnylam PharmaceuticalsPresident
Alnylam PharmaceuticalsPresident
Alnylam PharmaceuticalsPresident and Chief Operating Officer
Alnylam PharmaceuticalsPresident and Chief Operating Officer
Alnylam PharmaceuticalsPresident and Chief Operating Officer
Source: SEC filings on April 28, 2022, April 29, 2021, April 2, 2021, March 23, 2018, March 17, 2016, March 10, 2015, April 29, 2014, May 2, 2011, and April 20, 2010.
Related executives
We found 20 more executives who work or worked at Sage Therapeutics and Alnylam Pharmaceuticals.
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
Christopher Benecchi
Sage Therapeutics